Alpha Centric Advisors LLC Edgewise Therapeutics, Inc. Transaction History
Alpha Centric Advisors LLC
- $97.4 Million
- Q4 2024
A detailed history of Alpha Centric Advisors LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 10,316 shares of EWTX stock, worth $275,540. This represents 0.28% of its overall portfolio holdings.
Number of Shares
10,316Holding current value
$275,540% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
216Shares Held
98.4MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$401 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$238 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$164 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$161 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$134 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.69B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...